Cargando…

Perceived acceptability of progesterone to prevent preterm births and low birth weight among HIV-infected and HIV-uninfected Zambian pregnant women

INTRODUCTION: Intramuscular and vaginal progesterone are recommended for prevention of preterm labor (PTL) in women with risk factors. Studies are emerging to indicate that HIV-infected women on combination antiretroviral therapy (cART) are at risk of PTL and low birth weight (LBW), and may benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Jeffrey Man Hay, Kanga, Neha, Dogra, Nupur, Ngoma, Mary Shilalukey, Serghides, Lena, Silverman, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695261/ https://www.ncbi.nlm.nih.gov/pubmed/29180906 http://dx.doi.org/10.2147/IJWH.S136191

Ejemplares similares

Progesterone and preterm birth
por: Norman, Jane E.
Publicado: (2020)

Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants
por: Slyker, Jennifer A, et al.
Publicado: (2014)

Prevention of Preterm Birth with Progesterone
por: Di Renzo, Gian Carlo, et al.
Publicado: (2021)

The Zambian Preterm Birth Prevention Study (ZAPPS): Cohort characteristics at enrollment
por: Castillo, Marcela C., et al.
Publicado: (2019)

The role of progesterone in prevention of preterm birth
por: Dodd, Jodie M, et al.
Publicado: (2010)

Progesterone Action in the Myometrium and Decidua in Preterm Birth
por: Blanks, A.M., et al.
Publicado: (2012)

Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study
por: Price, Joan T., et al.
Publicado: (2020)

Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age
por: Rosala-Hallas, Anna, et al.
Publicado: (2017)

Preterm birth prevention—Time to PROGRESS beyond progesterone
por: Norman, Jane E., et al.
Publicado: (2017)

The use of progesterone during pregnancy to prevent preterm birth
por: Alsulmi, Eman S., et al.
Publicado: (2020)

Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study
Publicado: (2021)

Preterm Birth in Women With HIV: The Role of the Placenta
por: Ikumi, Nadia M., et al.
Publicado: (2022)

Progesterone Interactions with the Cervix: Translational Implications for Term and Preterm Birth
por: Larsen, Bryan, et al.
Publicado: (2011)

Progesterone for the Prevention of Preterm Birth – an Update of Evidence-Based Indications
por: Kuon, Ruben-J., et al.
Publicado: (2019)

Association of Vaginal Progesterone Treatment With Prevention of Recurrent Preterm Birth
por: Nelson, David B., et al.
Publicado: (2022)

Surviving and Thriving—Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop
por: Slogrove, Amy L., et al.
Publicado: (2018)

Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies
por: Kala, Smriti, et al.
Publicado: (2020)

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
por: Price, Joan T., et al.
Publicado: (2017)

Low Birth Weight in Perinatally HIV-Exposed Uninfected Infants: Observations in Urban Settings in Cameroon
por: Sofeu, Casimir Ledoux, et al.
Publicado: (2014)

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial
por: Lim, Arianne C, et al.
Publicado: (2007)

Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety
por: How, Helen Y, et al.
Publicado: (2009)

Progesterone Receptor (PGR) gene polymorphism is associated with susceptibility to preterm birth
por: Langmia, Immaculate Mbongo, et al.
Publicado: (2015)

Use of progesterone supplement therapy for prevention of preterm birth: review of literatures
por: Choi, Suk-Joo
Publicado: (2017)

Progesterone effects on vaginal cytokines in women with a history of preterm birth
por: Garry, David J., et al.
Publicado: (2018)

Adverse birth outcomes and their clinical phenotypes in an urban Zambian cohort
por: Price, Joan T, et al.
Publicado: (2020)

Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy
por: Nicholson, Laura, et al.
Publicado: (2015)

Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study
por: Wedderburn, Catherine J, et al.
Publicado: (2019)

Metabolomic profiling of preterm birth in pregnant women living with HIV
por: Tobin, Nicole H., et al.
Publicado: (2023)

Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort
por: Sevenoaks, Tatum, et al.
Publicado: (2021)

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy
por: Khandelwal, Meena
Publicado: (2012)

Use of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disorders
por: Garfield, R.E., et al.
Publicado: (2012)

Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women
por: Mnqonywa, Nonzwakazi, et al.
Publicado: (2019)

Placental Structure in Preterm Birth Among HIV-Positive Versus HIV-Negative Women in Kenya
por: Obimbo, Moses M., et al.
Publicado: (2019)

HIV-Positive and HIV-Negative Women with Medicaid Have Similar Rates of Stillbirth and Preterm Birth
por: Thompson, Kathryn D., et al.
Publicado: (2022)

HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction
por: Papp, Eszter, et al.
Publicado: (2015)

HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
por: Mohammadi, Hakimeh, et al.
Publicado: (2018)

Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History
por: Wang, Shao-Wei, et al.
Publicado: (2016)

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
por: Kindinger, Lindsay M., et al.
Publicado: (2017)

Progesterone for prevention of preterm birth in women with short cervical length: 2‐year infant outcomes
por: Cuijpers, C. J. J., et al.
Publicado: (2021)

Correction to “Notification: Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone”
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aa66aig906u9f58bacdqoivq8d